Journal of Travel Medicine
Oxford University Press
image
Angiotension-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection
DOI 10.1093/jtm/taaa069
  • PDF   
  • XML   
  •       

Highlights

Notes

Abstract

In a large Israeli dataset of 14 520 individuals tested for SARS-CoV-2, angiotension-converting enzyme inhibitors and angiotensin-receptor blockers were not found to be associated with increased SARS-CoV-2 infection after adjusting for major confounders. Patients on these medications should not stop their medication prophylactically.

Chodick, Nutman, Yiekutiel, and Shalev: Angiotension-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection
https://www.researchpad.co/tools/openurl?pubtype=article&doi=10.1093/jtm/taaa069&title=Angiotension-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection&author=Gabriel Chodick,Amir Nutman,Naama Yiekutiel,Varda Shalev,&keyword=&subject=Research Letter,